Department of Cellular and Molecular Medicine, University of Ottawa, 451 Smyth Road, Ottawa, ON, K1H 8M5, Canada.
Breast Cancer Res. 2022 Jun 9;24(1):40. doi: 10.1186/s13058-022-01536-w.
The Bcl-3 protein is an atypical member of the inhibitor of -κB family that has dual roles as a transcriptional repressor and a coactivator for dimers of NF-κB p50 and p52. Bcl-3 is expressed in mammary adenocarcinomas and can promote tumorigenesis and survival signaling and has a key role in tumor metastasis. In this study, we have investigated the role of Bcl-3 in the normal mammary gland and impact on tumor pathology.
We utilized bcl-3 mice to study mammary gland structure in virgins and during gestation, lactation and early involution. Expression of involution-associated genes and proteins and putative Bcl-3 target genes was examined by qRT-PCR and immunoblot analysis. Cell autonomous branching morphogenesis and collagen I invasion properties of bcl-3 organoids were tested in 3D hydrogel cultures. The role of Bcl-3 in tumorigenesis and tumor pathology was also assessed using a stochastic carcinogen-induced mammary tumor model.
Bcl-3 mammary glands demonstrated reduced branching complexity in virgin and pregnant mice. This defect was recapitulated in vitro where significant defects in bud formation were observed in bcl-3 mammary organoid cultures. Bcl-3 organoids showed a striking defect in protrusive collective fibrillary collagen I invasion associated with reduced expression of Fzd1 and Twist2. Virgin and pregnant bcl-3 glands showed increased apoptosis and rapid increases in lysosomal cell death and apoptosis after forced weaning compared to WT mice. Bcl-2 and Id3 are strongly induced in WT but not bcl-3 glands in early involution. Tumors in WT mice were predominately adenocarcinomas with NF-κB activation, while bcl-3 lesions were largely squamous lacking NF-κB and with low Bcl-2 expression.
Collectively, our results demonstrate that Bcl-3 has a key function in mammary gland branching morphogenesis, in part by regulation of genes involved in extracellular matrix invasion. Markedly reduced levels of pro-survival proteins expression in bcl-3 null compared to WT glands 24 h post-weaning indicate that Bcl-3 has a role in moderating the rate of early phase involution. Lastly, a reduced incidence of bcl-3 mammary adenocarcinomas versus squamous lesions indicates that Bcl-3 supports the progression of epithelial but not metaplastic cancers.
Bcl-3 蛋白是一种非典型的 IκB 抑制剂家族成员,具有作为 NF-κB p50 和 p52 二聚体转录抑制剂和共激活子的双重作用。Bcl-3 在乳腺腺癌中表达,并能促进肿瘤发生和生存信号转导,在肿瘤转移中起关键作用。在这项研究中,我们研究了 Bcl-3 在正常乳腺中的作用及其对肿瘤病理学的影响。
我们利用 bcl-3 小鼠研究了处女期和妊娠期、哺乳期和早期退化期乳腺的结构。通过 qRT-PCR 和免疫印迹分析检测退化相关基因和蛋白以及潜在的 Bcl-3 靶基因的表达。在 3D 水凝胶培养物中测试了 bcl-3 类器官的细胞自主分支形态发生和胶原 I 浸润特性。还使用随机致癌物诱导的乳腺肿瘤模型评估了 Bcl-3 在肿瘤发生和肿瘤病理学中的作用。
Bcl-3 乳腺在处女期和怀孕期小鼠中的分支复杂性降低。这种缺陷在体外得到了重现,在 bcl-3 乳腺类器官培养物中观察到芽形成的显著缺陷。Bcl-3 类器官在突出的纤维状胶原 I 浸润方面表现出明显的缺陷,与 Fzd1 和 Twist2 的表达降低有关。与 WT 小鼠相比,强迫断奶后,处女期和怀孕期 bcl-3 乳腺的细胞凋亡增加,溶酶体细胞死亡和凋亡迅速增加。在早期退化过程中,WT 乳腺中强烈诱导 Bcl-2 和 Id3,但 bcl-3 乳腺中不诱导。WT 小鼠的肿瘤主要为腺癌细胞,NF-κB 激活,而 bcl-3 病变主要为鳞状细胞,缺乏 NF-κB,Bcl-2 表达水平低。
总之,我们的结果表明,Bcl-3 在乳腺分支形态发生中具有关键作用,部分通过调节细胞外基质浸润相关基因的表达。与 WT 乳腺相比,断奶后 24 小时 bcl-3 缺失小鼠中促生存蛋白的表达水平明显降低,表明 Bcl-3 在调节早期退化阶段的速度方面发挥作用。最后,bcl-3 乳腺腺癌的发生率低于鳞状病变,表明 Bcl-3 支持上皮癌而不是化生癌的进展。